<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38187378</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Mitochondrial oxidative stress, mitochondrial ROS storms in long COVID pathogenesis.</ArticleTitle><Pagination><StartPage>1275001</StartPage><MedlinePgn>1275001</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1275001</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1275001</ELocationID><Abstract><AbstractText Label="SIGNIFICANCE">This review discusses the coronavirus disease 2019 (COVID-19) pathophysiology in the context of diabetes and intracellular reactions by COVID-19, including mitochondrial oxidative stress storms, mitochondrial ROS storms, and long COVID.</AbstractText><AbstractText Label="RECENT ADVANCES">The long COVID is suffered in ~10% of the COVID-19 patients. Even the virus does not exist, the patients suffer the long COVID for even over a year, This disease could be a mitochondria dysregulation disease.</AbstractText><AbstractText Label="CRITICAL ISSUES">Patients who recover from COVID-19 can develop new or persistent symptoms of multi-organ complications lasting weeks or months, called long COVID. The underlying mechanisms involved in the long COVID is still unclear. Once the symptoms of long COVID persist, they cause significant damage, leading to numerous, persistent symptoms.</AbstractText><AbstractText Label="FUTURE DIRECTIONS">A comprehensive map of the stages and pathogenetic mechanisms related to long COVID and effective drugs to treat and prevent it are required, which will aid the development of future long COVID treatments and symptom relief.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Noonong, Chatatikun, Surinkaew, Kotepui, Hossain, Bunluepuech, Noothong, Tedasen, Klangbud, Imai, Kawakami, Kubo, Kitagawa, Ichikawa, Kanekura, Sukati, Somsak, Udomwech, Ichikawa, Nissapatorn, Tangpong, Indo and Majima.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Noonong</LastName><ForeName>Kunwadee</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Excellence Center for Innovation and Health Products (RECIHP), School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Chatatikun</LastName><ForeName>Moragot</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Excellence Research for Melioidosis and Microorganisms, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Surinkaew</LastName><ForeName>Sirirat</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Excellence Research for Melioidosis and Microorganisms, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kotepui</LastName><ForeName>Manas</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hossain</LastName><ForeName>Rahni</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bunluepuech</LastName><ForeName>Kingkan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>School of Medicine, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noothong</LastName><ForeName>Chanittha</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tedasen</LastName><ForeName>Aman</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Excellence Center for Innovation and Health Products (RECIHP), School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klangbud</LastName><ForeName>Wiyada Kwanhian</ForeName><Initials>WK</Initials><AffiliationInfo><Affiliation>School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Excellence Center for Innovation and Health Products (RECIHP), School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Imai</LastName><ForeName>Motoki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Molecular Diagnostics, School of Allied Health Sciences, Kitasato University, Sagamihara, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Regenerative Medicine and Cell Design Research Facility, School of Allied Health Sciences, Kitasato University, Sagamihara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kawakami</LastName><ForeName>Fumitaka</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Regenerative Medicine and Cell Design Research Facility, School of Allied Health Sciences, Kitasato University, Sagamihara, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Regulation Biochemistry, Kitasato University Graduate School of Medical Sciences, Sagamihara, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Administration, School of Allied Health Sciences, Kitasato University, Sagamihara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kubo</LastName><ForeName>Makoto</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Regenerative Medicine and Cell Design Research Facility, School of Allied Health Sciences, Kitasato University, Sagamihara, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Microbiology, School of Allied Health Sciences, Kitasato University, Sagamihara, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Environmental Microbiology, Graduate School of Medical Sciences, Kitasato University, Sagamihara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kitagawa</LastName><ForeName>Yoshimasa</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Oral Diagnosis and Medicine, Division of Oral Pathobiological Science, Graduate School of Dental Medicine, Hokkaido University, Sapporo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ichikawa</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Graduate School of Life and Medical Sciences, Doshisha University, Kyoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanekura</LastName><ForeName>Takuro</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sukati</LastName><ForeName>Suriyan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Somsak</LastName><ForeName>Voravuth</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Excellence Center for Innovation and Health Products (RECIHP), School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Udomwech</LastName><ForeName>Lunla</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Medicine, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ichikawa</LastName><ForeName>Takafumi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Regenerative Medicine and Cell Design Research Facility, School of Allied Health Sciences, Kitasato University, Sagamihara, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Regulation Biochemistry, Kitasato University Graduate School of Medical Sciences, Sagamihara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nissapatorn</LastName><ForeName>Veeranoot</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Excellence Center for Innovation and Health Products (RECIHP), School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tangpong</LastName><ForeName>Jitbanjong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Excellence Center for Innovation and Health Products (RECIHP), School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Indo</LastName><ForeName>Hiroko P</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>Department of Oncology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amanogawa Galaxy Astronomy Research Center, Kagoshima University Graduate School of Engineering, Kagoshima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Majima</LastName><ForeName>Hideyuki J</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Excellence Center for Innovation and Health Products (RECIHP), School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Lancet. 2020 Feb 15;395(10223):514-523. doi: 10.1016/S0140-6736(20)30154-9</RefSource><PMID Version="1">31986261</PMID></CommentsCorrections><CommentsCorrections RefType="CommentOn"><RefSource>Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5</RefSource><PMID Version="1">31986264</PMID></CommentsCorrections><CommentsCorrections RefType="CommentOn"><RefSource>Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7</RefSource><PMID Version="1">32007143</PMID></CommentsCorrections><CommentsCorrections RefType="CommentOn"><RefSource>Lancet. 2020 Feb 22;395(10224):565-574. doi: 10.1016/S0140-6736(20)30251-8</RefSource><PMID Version="1">32007145</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">long Covid</Keyword><Keyword MajorTopicYN="N">mitochondria</Keyword><Keyword MajorTopicYN="N">mitochondrial ROS storms</Keyword><Keyword MajorTopicYN="N">oxidative stress</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>9</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>8</Day><Hour>4</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38187378</ArticleId><ArticleId IdType="pmc">PMC10766822</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1275001</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Carvalho T, Krammer F, Iwasaki A. The first 12 months of COVID-19: a timeline of immunological insights. Nat Rev Immunol (2021) 21:245&#x2013;56. doi:&#xa0;10.1038/s41577-021-00522-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00522-1</ArticleId><ArticleId IdType="pmc">PMC7958099</ArticleId><ArticleId IdType="pubmed">33723416</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (2020) 395(10223):497&#x2013;506. doi:&#xa0;10.1016/S0140-6736(20)30183-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. . Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet (2020) 395(10223):507&#x2013;13. doi:&#xa0;10.1016/S0140-6736(20)30211-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30211-7</ArticleId><ArticleId IdType="pmc">PMC7135076</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. . A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet (2020) 395(10223):514523. doi:&#xa0;10.1016/S0140-6736(20)30154-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30154-9</ArticleId><ArticleId IdType="pmc">PMC7159286</ArticleId><ArticleId IdType="pubmed">31986261</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. . Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet (2020) 395:565&#x2013;74. doi:&#xa0;10.1016/S0140-6736(20)30251-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30251-8</ArticleId><ArticleId IdType="pmc">PMC7159086</ArticleId><ArticleId IdType="pubmed">32007145</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Peng F, Wang R, Yange M, Guan K, Jiang T, et al. . The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China. J Autoimmun (2020) 109:102434. doi:&#xa0;10.1016/j.jaut.2020.102434</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2020.102434</ArticleId><ArticleId IdType="pmc">PMC7126544</ArticleId><ArticleId IdType="pubmed">32143990</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature (2020) 579(7798):270&#x2013;3. doi:&#xa0;10.1038/s41586-020-2012-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2012-7</ArticleId><ArticleId IdType="pmc">PMC7095418</ArticleId><ArticleId IdType="pubmed">32015507</ArticleId></ArticleIdList></Reference><Reference><Citation>Seyed Hosseini E, Riahi Kashani N, Nikzad H, Azadbakht J, Hassani Bafrani H, Hadded Kashani H. The novel coronavirus disease-2019 (COVID-19): mechanism of action, detection and recent therapeutic strategies. Virology (2020) 551:1&#x2013;9. doi:&#xa0;10.1016/j.virol.2020.08.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2020.08.011</ArticleId><ArticleId IdType="pmc">PMC7513802</ArticleId><ArticleId IdType="pubmed">33010669</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang X, Wu C, Li X, Song Y, Yao X, Wu X, et al. . On the origin and continuing evolution of SARS-CoV-2. Natl Sci Rev (2020) 7:1012&#x2013;23. doi:&#xa0;10.1093/nsr/nwaa036</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nsr/nwaa036</ArticleId><ArticleId IdType="pmc">PMC7107875</ArticleId><ArticleId IdType="pubmed">34676127</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. . A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med (2020) 382:727&#x2013;33. doi:&#xa0;10.1056/NEJMoa2001017</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001017</ArticleId><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. . A new coronavirus associated with human respiratory disease in China. Nature (2020) 579(7798):265&#x2013;9. doi:&#xa0;10.1038/s41586-020-2008-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2008-3</ArticleId><ArticleId IdType="pmc">PMC7094943</ArticleId><ArticleId IdType="pubmed">32015508</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazarevic I, Pravica V, Miljanovic D, Cupic M. Immune evasion of SARS-CoV-2 emerging variants: what have we learnt so far? Viruses (2021) 13:1192. doi:&#xa0;10.3390/v13071192</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13071192</ArticleId><ArticleId IdType="pmc">PMC8310325</ArticleId><ArticleId IdType="pubmed">34206453</ArticleId></ArticleIdList></Reference><Reference><Citation>Burki TK. Lifting of COVID-19 restrictions in the UK and the Delta variant. Lancet Respir Med (2021) 9:e85. doi:&#xa0;10.1016/S2213-2600(21)00328-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00328-3</ArticleId><ArticleId IdType="pmc">PMC8275031</ArticleId><ArticleId IdType="pubmed">34265238</ArticleId></ArticleIdList></Reference><Reference><Citation>Noori M, Nejadghaderi SA, Arshi S, Carson-Chahhoud K, Ansarin K, Kolahi AA, et al. . Potency of BNT162b2 and mRNA-1273 vaccine-induced neutralizing antibodies against severe acute respiratory syndrome-CoV-2 variants of concern: A systematic review of in vitro studies. Rev Med Virol (2022) 32:e2277. doi:&#xa0;10.1002/rmv.2277</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2277</ArticleId><ArticleId IdType="pmc">PMC8420542</ArticleId><ArticleId IdType="pubmed">34286893</ArticleId></ArticleIdList></Reference><Reference><Citation>
National Institute for Health and Care Excellence . COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19 (2020). NG188. Available at: https://www.nice.org.uk/guidance/ng188 (Accessed 12 December 2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Karim SSA, Karim QA. Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic. Lancet (2021) 398:2126&#x2013;8. doi:&#xa0;10.1016/S0140-6736(21)02758-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02758-6</ArticleId><ArticleId IdType="pmc">PMC8640673</ArticleId><ArticleId IdType="pubmed">34871545</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. . Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA (2020) 323(11):1061&#x2013;9. doi:&#xa0;10.1001/jama.2020.1585</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1585</ArticleId><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. . Attributes and predictors of long COVID. Nat Med (2021) 27(4):626&#x2013;31. doi:&#xa0;10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>
Centers for Disease Control and Prevention, National Center for Health Statistics . Nearly One in Five American Adults Who Have Had COVID-19 Still Have &#x201c;Long COVID&#x201d; (2022). Available at: https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2022/20220622.html.</Citation></Reference><Reference><Citation>Hussain S, Baxi H, Chand Jamali M, Nisar N, Hussain MS. Burden of diabetes mellitus and its impact on COVID-19 patients: A meta-analysis of real-world evidence. Diabetes Metab Syndr (2020) 14:1595&#x2013;602. doi:&#xa0;10.1016/j.dsx.2020.08.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.08.014</ArticleId><ArticleId IdType="pmc">PMC7439970</ArticleId><ArticleId IdType="pubmed">32862098</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang L, Shao M, Guo Q, Shi J, Zhao Y, Xiaokerati J, et al. . Diabetes mellitus is associated with severe infection and mortality in patients with COVID-19: A systematic review and meta-analysis. Arch Med Res (2020) 51:700&#x2013;9. doi:&#xa0;10.1016/j.arcmed.2020.07.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcmed.2020.07.005</ArticleId><ArticleId IdType="pmc">PMC7413048</ArticleId><ArticleId IdType="pubmed">32811670</ArticleId></ArticleIdList></Reference><Reference><Citation>Saha S, Al-Rifai RH, Saha S. Diabetes prevalence and mortality in COVID-19 patients: a systematic review, meta-analysis, and meta-regression. J Diabetes Metab Disord (2021) 20:939&#x2013;50. doi:&#xa0;10.1007/s40200-021-00779-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40200-021-00779-2</ArticleId><ArticleId IdType="pmc">PMC8012080</ArticleId><ArticleId IdType="pubmed">33821206</ArticleId></ArticleIdList></Reference><Reference><Citation>Palaiodimos L, Chamorro-Pareja N, Karamanis D, Li W, Zavras PD, Chang KM, et al. . Diabetes is associated with increased risk for in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis comprising 18,506 patients. Hormones (2021) 20:305&#x2013;14. doi:&#xa0;10.1007/s42000-020-00246-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42000-020-00246-2</ArticleId><ArticleId IdType="pmc">PMC7595056</ArticleId><ArticleId IdType="pubmed">33123973</ArticleId></ArticleIdList></Reference><Reference><Citation>Corona G, Pizzocaro A, Vena W, Rastrelli G, Semeraro F, Isidori AM, et al. . Diabetes is most important cause for mortality in COVID-19 hospitalized patients: Systematic review and meta-analysis. Rev Endocr Metab Disord (2021) 22:275&#x2013;96. doi:&#xa0;10.1007/s11154-021-09630-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11154-021-09630-8</ArticleId><ArticleId IdType="pmc">PMC7899074</ArticleId><ArticleId IdType="pubmed">33616801</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta P, Gupta M, KAtoch N, Garg K, Garg B. A systematic review and meta-analysis of diabetes associated mortality in patients with COVID-19. Int J Endocrinol Metabol (2021) 19:e113220. doi:&#xa0;10.5812/ijem.113220</Citation><ArticleIdList><ArticleId IdType="doi">10.5812/ijem.113220</ArticleId><ArticleId IdType="pmc">PMC8762284</ArticleId><ArticleId IdType="pubmed">35069750</ArticleId></ArticleIdList></Reference><Reference><Citation>Ssentongo P, Zhang Y, Witmer L, Chinchilli VM, Ba DM. Association of COVID-19 with diabetes: a systematic review and meta-analysis. Sci Rep (2022) 2:20191. doi:&#xa0;10.1038/s41598-022-24185-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-24185-7</ArticleId><ArticleId IdType="pmc">PMC9684130</ArticleId><ArticleId IdType="pubmed">36418912</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu SP, Zhang Q, Wang W, Zhang M, Liu C, Xiao X, et al. . Hyperglycemia is a strong predictor of poor prognosis in COVID-19. Diabetes Res Clin Practi (2020) 167:108338. doi:&#xa0;10.1016/j.diabres.2020.108338</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2020.108338</ArticleId><ArticleId IdType="pmc">PMC7377976</ArticleId><ArticleId IdType="pubmed">32712122</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul BD, Lemle MD, Komaroff AL, Snyder SH. Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome. Proc Natl Acad Sci U.S.A. (2021) 118:e2024358118. doi:&#xa0;10.1073/pnas.2024358118</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2024358118</ArticleId><ArticleId IdType="pmc">PMC8403932</ArticleId><ArticleId IdType="pubmed">34400495</ArticleId></ArticleIdList></Reference><Reference><Citation>Steenblock C, Hassanein M, Khan EG, Yaman M, Kamel M, Barbir M, et al. . Diabetes and COVID-19: short- and long-term consequences. Horm Metab Res (2022) 54:503&#x2013;9. doi:&#xa0;10.1055/a-1878-9566</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1878-9566</ArticleId><ArticleId IdType="pmc">PMC9363150</ArticleId><ArticleId IdType="pubmed">35724689</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med (2022) 28:1461&#x2013;7. doi:&#xa0;10.1038/s41591-022-01840-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Al-Aly Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol (2022) 10(5):311&#x2013;21. doi:&#xa0;10.1016/S2213-8587(22)00044-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(22)00044-4</ArticleId><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizvi AA, Kathuria A, Al Mahmeed W, Al-Rasadi K, Al-Alawi K, Banach M, et al. . Post-COVID syndrome, inflammation, and diabetes. J Diabetes Complications (2022) 36(11):108336. doi:&#xa0;10.1016/j.jdiacomp.2022.108336</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jdiacomp.2022.108336</ArticleId><ArticleId IdType="pmc">PMC9534783</ArticleId><ArticleId IdType="pubmed">36228563</ArticleId></ArticleIdList></Reference><Reference><Citation>Bramante CT, Buse JB, Liebovitz DM, Nicklas JM, Puskarich MA, Cohen K, et al. . Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial. Lancet Infect Dis (2023) 23(10):1119&#x2013;29. doi:&#xa0;10.1016/S1473-3099(23)00299-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00299-2</ArticleId><ArticleId IdType="pmc">PMC11259948</ArticleId><ArticleId IdType="pubmed">37302406</ArticleId></ArticleIdList></Reference><Reference><Citation>V&#x2019;kovski P, Kratzel A, Steiner S, Stalder H, Thiel V. Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol (2021) 19(3):155&#x2013;70. doi:&#xa0;10.1038/s41579-020-00468-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-00468-6</ArticleId><ArticleId IdType="pmc">PMC7592455</ArticleId><ArticleId IdType="pubmed">33116300</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzi M, D&#x2019;Onghia D, Tonello S, Minisini R, Colangelo D, Bellan M, et al. . COVID-19 biomarkers at the crossroad between patient stratification and targeted therapy: The role of validated 95. and proposed parameters. Int J Mol Sci (2023) 24(8):7099. doi:&#xa0;10.3390/ijms2408709995</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms2408709995</ArticleId><ArticleId IdType="pmc">PMC10138390</ArticleId><ArticleId IdType="pubmed">37108262</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzi M, Costanzo M, Tonello S, Matino E, Casciaro FG, Croce A, et al. . Prognostic markers in Hospitalized COVID-19 patients: The role of IP-10 and C-reactive protein. Dis Markers (2022) 2022:3528312. doi:&#xa0;10.1155/2022/3528312</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/3528312</ArticleId><ArticleId IdType="pmc">PMC8886756</ArticleId><ArticleId IdType="pubmed">35242241</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzi M, Matino E, Costanzo M, Casciaro GF, Croce A, Rizzi E, et al. . Baseline plasma gas6 protein elevation predicts adverse outcomes in hospitalized COVID-19 patients. Dis Markers (2022) 1568352. doi:&#xa0;10.1155/2022/156835297</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/156835297</ArticleId><ArticleId IdType="pmc">PMC9070408</ArticleId><ArticleId IdType="pubmed">35531477</ArticleId></ArticleIdList></Reference><Reference><Citation>Apostolo D, D&#x2019;Onghia D, Tonello S, Minisini R, Baricich A, Gramaglia C, et al. . Decreased Gas6 and sAxl plasma levels are associated with hair loss in COVID-19 survivors. Int J Mol (2023) 24:6257. doi:&#xa0;10.3390/ijms24076257</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24076257</ArticleId><ArticleId IdType="pmc">PMC10094682</ArticleId><ArticleId IdType="pubmed">37047229</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonello S, Rizzi M, Matino E, Costanzo M, Casciaro GF, Croce A, et al. . Baseline plasma Gas6 protein elevation predicts adverse outcomes in hospitalized COVID-19 patients. Dis Markers (2022) 2022:1568352. doi:&#xa0;10.1155/2022/1568352</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/1568352</ArticleId><ArticleId IdType="pmc">PMC9070408</ArticleId><ArticleId IdType="pubmed">35531477</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Zhao B, Qu Y, Chen Y, Xiong J, Feng Y, et al. . Detectable serum severe acute respiratory syndrome Coronavirus 2 viral load (RNAemia) Is closely correlated with drastically elevated Interleukin 6 level in critically Ill patients with Coronavirus disease 2019. Clin Infect Dis (2020) 71:1937&#x2013;42. doi:&#xa0;10.1093/cid/ciaa449</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa449</ArticleId><ArticleId IdType="pmc">PMC7184354</ArticleId><ArticleId IdType="pubmed">32301997</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzi M, Tonello S, Morani F, Rizzi E, Casciaro GF, Matino E, et al. . CGRP plasma levels correlate with the clinical evolution and prognosis of hospitalized acute COVID-19 patients. Viruses (2022) 14:2123. doi:&#xa0;10.3390/v14102123</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14102123</ArticleId><ArticleId IdType="pmc">PMC9611580</ArticleId><ArticleId IdType="pubmed">36298678</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson CB, Farzan M, Chen B, Choe H. Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol (2022) 23:3&#x2013;20. doi:&#xa0;10.1038/s41580-021-00418-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-021-00418-x</ArticleId><ArticleId IdType="pmc">PMC8491763</ArticleId><ArticleId IdType="pubmed">34611326</ArticleId></ArticleIdList></Reference><Reference><Citation>Loffredo L, Violi F. COVID-19 and cardiovascular injury: A role for oxidative stress and antioxidant treatment? Int J Cardiol (2020) 312:136. doi:&#xa0;10.1016/j.ijcard.2020.04.066</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2020.04.066</ArticleId><ArticleId IdType="pmc">PMC7833193</ArticleId><ArticleId IdType="pubmed">32505331</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado-Roche L, Mesta F. Oxidative stress as key player in severe acute respiratory syndrome coronavirus (SARS-coV) infection. Arch Med Res (2020) 51:384&#x2013;7. doi:&#xa0;10.1016/j.arcmed.2020.04.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcmed.2020.04.019</ArticleId><ArticleId IdType="pmc">PMC7190501</ArticleId><ArticleId IdType="pubmed">32402576</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallick U. Pathogenesis of coViD19&#x2014;Miscellaneous mechanisms. In: Cardiovascular Complications of COVID-19. Cham: Springer; (2022).</Citation></Reference><Reference><Citation>Srinivasan K, Pandey AK, Livingston A, Venkatesh S. Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target? Mol BioMed (2021) 2:38. doi:&#xa0;10.1186/s43556-021-00060-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43556-021-00060-1</ArticleId><ArticleId IdType="pmc">PMC8608434</ArticleId><ArticleId IdType="pubmed">34841263</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh KK, Chaubey G, Chen JY, Suravajhala P. Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis. Am J Physiol Cell Physiol (2020) 1(319):C258&#x2013;67. doi:&#xa0;10.1152/ajpcell.00224.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00224.2020</ArticleId><ArticleId IdType="pmc">PMC7381712</ArticleId><ArticleId IdType="pubmed">32510973</ArticleId></ArticleIdList></Reference><Reference><Citation>Anand SK, Tikoo SK. Viruses aremodulators of mitochondrial functions. Adv Virol (2013) 2013:738794. doi:&#xa0;10.1155/2013/738794</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/738794</ArticleId><ArticleId IdType="pmc">PMC3821892</ArticleId><ArticleId IdType="pubmed">24260034</ArticleId></ArticleIdList></Reference><Reference><Citation>Claus C, Liebert UG. A renewed focus on the interplay between viruses and mitochondrial metabolism. Arch Virol (2014) 159:1267&#x2013;77. doi:&#xa0;10.1007/s00705-013-1841-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-013-1841-1</ArticleId><ArticleId IdType="pubmed">24343264</ArticleId></ArticleIdList></Reference><Reference><Citation>Glingston RS, Deb R, Kumar S, Nagotu S. Organelle dynamics and viral infections: at crossroads. Microbes Infect (2019) 21:20&#x2013;32. doi:&#xa0;10.1016/j.micinf.2018.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2018.06.002</ArticleId><ArticleId IdType="pmc">PMC7110583</ArticleId><ArticleId IdType="pubmed">29953921</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajaz S, McPhail MJ, Singh KK, Mujib S, Trovato FM, Napoli S, et al. . Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of patients with COVID-19. Am J Physiol Cell Physiol (2021) 320:C57&#x2013;65. doi:&#xa0;10.1152/ajpcell.00426.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00426.2020</ArticleId><ArticleId IdType="pmc">PMC7816428</ArticleId><ArticleId IdType="pubmed">33151090</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasun P. COVID-19: A mitochondrial perspective. DNA Cell Biol (2021) 40:713&#x2013;9. doi:&#xa0;10.1089/dna.2020.6453</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/dna.2020.6453</ArticleId><ArticleId IdType="pubmed">33872068</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Z, Yu Y, Chen C, Yang D, Ding T, Zhu L, et al. . The triangle relationship between long noncoding RNA, RIG-I-like receptor signaling pathway, and glycolysis. Front Microbiol (2021) 12:807737. doi:&#xa0;10.3389/fmicb.2021.807737</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.807737</ArticleId><ArticleId IdType="pmc">PMC8670088</ArticleId><ArticleId IdType="pubmed">34917069</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Wang G, Xu ZG, Tu H, Hu F, Dai J, et al. . Lactate is a natural suppressor of RLR signaling by targeting MAVS. Cell (2019) 178:176&#x2013;189.e15. doi:&#xa0;10.1016/j.cell.2019.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.05.003</ArticleId><ArticleId IdType="pmc">PMC6625351</ArticleId><ArticleId IdType="pubmed">31155231</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu M, Pei Z, Long G, Chen H, Jia Z, Xia W. Mitochondrial antiviral signaling protein: a potential therapeutic target in renal disease. Front Immunol (2023) 14:1266461. doi:&#xa0;10.3389/fimmu.2023.1266461</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1266461</ArticleId><ArticleId IdType="pmc">PMC10602740</ArticleId><ArticleId IdType="pubmed">37901251</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano-Teruel PM, Garc&#xed;a-La&#xed;nez G, Marco-Salvador M, Pardo J, Arias M, DeFord C, et al. . Identification of an ASC oligomerization inhibitor for the treatment of inflammatory diseases. Cell Death Dis (2021) 12:1155. doi:&#xa0;10.1038/s41419-021-04420-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-021-04420-1</ArticleId><ArticleId IdType="pmc">PMC8667020</ArticleId><ArticleId IdType="pubmed">34903717</ArticleId></ArticleIdList></Reference><Reference><Citation>Vald&#xe9;s-Aguayo JJ, Garza-Veloz I, Badillo-Almar&#xe1;z JI, Bernal-Silva S, Mart&#xed;nez-V&#xe1;zquez MC, Ju&#xe1;rez-Alcal&#xe1; V, et al. . Mitochondria and mitochondrial DNA: key elements in the pathogenesis and exacerbation of the inflammatory state caused by COVID-19. Medicina (Kaunas) (2021) 57:928. doi:&#xa0;10.3390/medicina57090928</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57090928</ArticleId><ArticleId IdType="pmc">PMC8471487</ArticleId><ArticleId IdType="pubmed">34577851</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci (2019) 20(13):3328. doi:&#xa0;10.3390/ijms20133328</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20133328</ArticleId><ArticleId IdType="pmc">PMC6651423</ArticleId><ArticleId IdType="pubmed">31284572</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno Fern&#xe1;ndez-Ayala DJ, Navas P, L&#xf3;pez-Lluch G. Age-related mitochondrial dysfunction as a key factor in COVID-19 disease. Exp Gerontol (2020) 142:111147. doi:&#xa0;10.1016/j.exger.2020.111147</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2020.111147</ArticleId><ArticleId IdType="pmc">PMC7648491</ArticleId><ArticleId IdType="pubmed">33171276</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbari H, Taghizadeh-Hesary F. COVID-19 induced liver injury from a new perspective: Mitochondria. Mitochondrion (2023) 70:103&#x2013;10. doi:&#xa0;10.1016/j.mito.2023.04.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2023.04.001</ArticleId><ArticleId IdType="pmc">PMC10088285</ArticleId><ArticleId IdType="pubmed">37054906</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasada Kabekkodu S, Chakrabarty S, Jayaram P, Mallya S, Thangaraj K, Singh KK, et al. . Severe acute respiratory syndrome coronaviruses contributing to mitochondrial dysfunction: Implications for post-COVID complications. Mitochondrion (2023) 69:43&#x2013;56. doi:&#xa0;10.1016/j.mito.2023.01.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2023.01.005</ArticleId><ArticleId IdType="pmc">PMC9854144</ArticleId><ArticleId IdType="pubmed">36690315</ArticleId></ArticleIdList></Reference><Reference><Citation>Guarnieri JW, Dybas JM, Fazelinia H, Kim MS, Frere J, Zhang Y, et al. . Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts. Sci Transl Med (2023) 15(708):eabq1533. doi:&#xa0;10.1126/scitranslmed.abq1533</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abq1533</ArticleId><ArticleId IdType="pubmed">37556555</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller B, Silverstein A, Flores M, Cao K, Kumagai H, Mehta HH, et al. . Host mitochondrial transcriptome response to SARS-CoV-2 in multiple cell models and clinical samples. Sci Rep (2021) 11:3. doi:&#xa0;10.1038/s41598-020-79552-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-79552-z</ArticleId><ArticleId IdType="pmc">PMC7794290</ArticleId><ArticleId IdType="pubmed">33420163</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhowal C, Ghosh S, Ghatak D, De R. Pathophysiological involvement of host mitochondria in SARS-CoV-2 infection that causes COVID-19: a comprehensive evidential insight. Mol Cell Biochem (2023) 478:1325&#x2013;43. doi:&#xa0;10.1007/s11010-022-04593-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-022-04593-z</ArticleId><ArticleId IdType="pmc">PMC9617539</ArticleId><ArticleId IdType="pubmed">36308668</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan C, Ma R, Zeng X, Chen B, Hou D, Liu R, et al. . SARS-CoV-2 achieves immune escape by destroying mitochondrial quality: Comprehensive analysis of the cellular landscapes of lung and blood specimens from patients with COVID-19. Front Immunol (2022) 13:946731. doi:&#xa0;10.3389/fimmu.2022.946731</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.946731</ArticleId><ArticleId IdType="pmc">PMC9283956</ArticleId><ArticleId IdType="pubmed">35844544</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Wu Y, Meng X, Wang Z, Younis M, Liu Y, et al. . SARS-CoV-2 membrane protein causes the mitochondrial apoptosis and pulmonary edema via targeting BOK. Cell Death Differ (2022) 29:1395&#x2013;408. doi:&#xa0;10.1038/s41418-022-00928-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-022-00928-x</ArticleId><ArticleId IdType="pmc">PMC8752586</ArticleId><ArticleId IdType="pubmed">35022571</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a Report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA (2020) 323:1239&#x2013;42. doi:&#xa0;10.1001/jama.2020.2648</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: an overview. Diabetes Metabo Syndr (2021) 15:869&#x2013;75. doi:&#xa0;10.1016/j.dsx.2021.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>
National Center for Immunization and Respiratory Diseases. Division of Viral Diseases. Centers for Disease Control and Prevention . Long COVID or post-COVID conditions (2022). Available at: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html (Accessed 28 November 2022).</Citation></Reference><Reference><Citation>Nguyen NN, Hoang VT, Dao TL, Meddeb L, Lagier JC, Million M, et al. . Long-term persistence of symptoms of dyspnoea in COVID-19 patients. Int J Infect Dis (2022) 115:17&#x2013;23. doi:&#xa0;10.1016/j.ijid.2021.11.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.11.035</ArticleId><ArticleId IdType="pmc">PMC8627107</ArticleId><ArticleId IdType="pubmed">34848374</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ (2021) 374:n1648. doi:&#xa0;10.1136/bmj.n1648</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>
Garner P. For 7 weeks I have been through a roller coaster of ill health, extreme emotions, and utter exhaustion (2020). Available at: https://blogs.bmj.com/bmj/2020/05/05/paul-garner-people-who-have-a-more-protracted-illness-need-help-to-understand-and-cope-with-the-constantly-shifting-bizarre-symptoms (Accessed 5 May 2021).</Citation></Reference><Reference><Citation>
National Institute for Health and Care Excellence . COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19 (2020) . NG188. Available at: https://www.nice.org.uk/guidance/ng188 (Accessed 12 December 2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta SD, Talwar A, Lee JT. A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: illness beyond acute infection and public health implications. JAMA (2020) 324:2251&#x2013;2. doi:&#xa0;10.1001/jama.2020.22717</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.22717</ArticleId><ArticleId IdType="pubmed">33206133</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol (2023) 21:133&#x2013;46. doi:&#xa0;10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrea L, Verde L, Grant WB, Frias-Toral E, Sarno G, Vetrani C, et al. . Vitamin D: A role also in long COVID-19? Nutrients (2022) 14:1625. doi:&#xa0;10.3390/nu14081625</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14081625</ArticleId><ArticleId IdType="pmc">PMC9028162</ArticleId><ArticleId IdType="pubmed">35458189</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. . Post-acute COVID-19 syndrome. Nat Med (2021) 27:601&#x2013;15. doi:&#xa0;10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman L, Bested AC, Bonilla HF, Chheda BV, Chu L, Curtin JM, et al. . Myalgic encephalomyelitis/chronic fatigue syndrome: essentials of diagnosis and management. Mayo Clin Proc (2021) 96:2861&#x2013;78. doi:&#xa0;10.1016/j.mayocp.2021.07.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.07.004</ArticleId><ArticleId IdType="pubmed">34454716</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood E, Hall KH, Tate W. Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: A possible approach to SARS-CoV-2 &#x2018;long-haulers&#x2019;? Chronic Dis Transl Med (2021) 7:14&#x2013;26. doi:&#xa0;10.1016/j.cdtm.2020.11.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cdtm.2020.11.002</ArticleId><ArticleId IdType="pmc">PMC7680046</ArticleId><ArticleId IdType="pubmed">33251031</ArticleId></ArticleIdList></Reference><Reference><Citation>Azcue N, Del Pino R, Acera M, Fern&#xe1;ndez-Valle T, Ayo-Mentxakatorre N, P&#xe9;rez-Concha T, et al. . Dysautonomia and small fiber neuropathy in post-COVID condition and Chronic Fatigue Syndrome. J Transl Med (2023) 21:814. doi:&#xa0;10.1186/s12967-023-04678-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-023-04678-3</ArticleId><ArticleId IdType="pmc">PMC10648633</ArticleId><ArticleId IdType="pubmed">37968647</ArticleId></ArticleIdList></Reference><Reference><Citation>Linnhoff S, Koehler L, Haghikia A, Zaehle T. The therapeutic potential of non-invasive brain stimulation for the treatment of Long-COVID-related cognitive fatigue. Front Immunol (2023) 13:935614. doi:&#xa0;10.3389/fimmu.2022.935614</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.935614</ArticleId><ArticleId IdType="pmc">PMC9869163</ArticleId><ArticleId IdType="pubmed">36700201</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M, Apostolo D, Alb&#xe8; A, Crevola M, Errica N, Ratano G, et al. . Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: A prospective cohort study. Front Immunol (2022) 13:1038227. doi:&#xa0;10.3389/fimmu.2022.1038227</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1038227</ArticleId><ArticleId IdType="pmc">PMC9807078</ArticleId><ArticleId IdType="pubmed">36601115</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunn AVW, Guy GW, Brysch W, Bell JD. Understanding long COVID; mitochondrial health and adaptation-old pathways, new problems. Biomedicines (2022) 10:3113. doi:&#xa0;10.3390/biomedicines10123</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10123</ArticleId><ArticleId IdType="pmc">PMC9775339</ArticleId><ArticleId IdType="pubmed">36551869</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollbracht C, Kraft K. Oxidative stress and hyper-inflammation as major drivers of severe COVID-19 and long COVID: implications for the benefit of high-dose intravenous vitamin C. Front Pharmacol (2022) 13:899198. doi:&#xa0;10.3389/fphar.2022.899198</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.899198</ArticleId><ArticleId IdType="pmc">PMC9100929</ArticleId><ArticleId IdType="pubmed">35571085</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Hern&#xe1;ndez Y, Mon&#xe1;rrez-Espino J, L&#xf3;pez DAG, Zheng J, Borrego JC, Torres-Calzada C, et al. . The plasma metabolome of long COVID patients two years after infection. Sci Rep (2023) 1(13):12420. doi:&#xa0;10.1038/s41598-023-39049-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-39049-x</ArticleId><ArticleId IdType="pmc">PMC10394026</ArticleId><ArticleId IdType="pubmed">37528111</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpen&#xe8; G, Onorato D, Nocini R, Fortunato G, Rizk JG, Henry BM, et al. . Blood lactate concentration in COVID-19: a systematic literature review. Clin Chem Lab Med (2021) 60:332&#x2013;7. doi:&#xa0;10.1515/cclm-2021-1115</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2021-1115</ArticleId><ArticleId IdType="pubmed">34856090</ArticleId></ArticleIdList></Reference><Reference><Citation>Wendel Garcia PD, Fumeaux T, Guerci P, Heuberger DM, Montomoli J, Roche-Campo F, et al. . Prognostic factors associated with mortality risk and disease progression in 639 critically ill patients with COVID-19 in Europe: Initial report of the international RISC-19-ICU prospective observational cohort. EClinicalMedicine (2020) 25:100449. doi:&#xa0;10.1016/j.eclinm.2020.100449</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100449</ArticleId><ArticleId IdType="pmc">PMC7338015</ArticleId><ArticleId IdType="pubmed">32838231</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira J, Gameiro J, Bernardo J, Marques F, Costa C, Branco C, et al. . Impact of chronic RAAS use in elderly COVID-19 patients: A retrospective analysis. J Clin Med (2021) 10:3147. doi:&#xa0;10.3390/jcm10143147</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10143147</ArticleId><ArticleId IdType="pmc">PMC8307646</ArticleId><ArticleId IdType="pubmed">34300311</ArticleId></ArticleIdList></Reference><Reference><Citation>Alharthy A, Aletreby W, Faqihi F, Balhamar A, Alaklobi F, Alanezi K, et al. . Clinical characteristics and predictors of 28-day mortality in 352 critically ill patients with COVID-19: A retrospective study. J Epidemiol Glob Health (2021) 11:98&#x2013;104. doi:&#xa0;10.2991/jegh.k.200928.001</Citation><ArticleIdList><ArticleId IdType="doi">10.2991/jegh.k.200928.001</ArticleId><ArticleId IdType="pmc">PMC7958266</ArticleId><ArticleId IdType="pubmed">33095982</ArticleId></ArticleIdList></Reference><Reference><Citation>Birben B, Birben OD, Ak&#x131;n T, Akkurt G, Surel AA, Yak&#x131;s&#x131;k E, et al. . Efficacy of the delta neutrophil index in predicting 30-day mortality in COVID-19 patients requiring intensive care. Int J Clin Pract (2021) 75:e13970. doi:&#xa0;10.1111/ijcp.13970</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.13970</ArticleId><ArticleId IdType="pmc">PMC7883061</ArticleId><ArticleId IdType="pubmed">33368905</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassiliou AG, Jahaj E, Ilias I, Markaki V, Malachias S, Vretoo C, et al. . Lactate kinetics reflect organ dysfunction and are associated with adverse outcomes in intensive care unit patients with COVID-19 pneumonia: preliminary results from a Greek single-centre study. Metabolites (2020) 10:386. doi:&#xa0;10.3390/metabo10100386</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo10100386</ArticleId><ArticleId IdType="pmc">PMC7599563</ArticleId><ArticleId IdType="pubmed">32998323</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Nie HX, Hu K, Wu XJ, Zhang YT, Wang MM, et al. . Abnormal immunity of non-survivors with COVID-19: predictors for mortality. Infect Dis Poverty (2020) 9:108. doi:&#xa0;10.1186/s40249-020-00723-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40249-020-00723-1</ArticleId><ArticleId IdType="pmc">PMC7396941</ArticleId><ArticleId IdType="pubmed">32746940</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarfaraz S, Shaikh Q, Saleem SG, Rahim A, Herekar FF, Junejo S, et al. . Determinants of in-hospital mortality in COVID-19; a prospective cohort study from Pakistan. PloS One (2021) 16:e0251754. doi:&#xa0;10.1371/journal.pone.0251754</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0251754</ArticleId><ArticleId IdType="pmc">PMC8158897</ArticleId><ArticleId IdType="pubmed">34043674</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalabin A, Mani VRK, Valdivieso SC, Donaldson B. Role of neutrophil-to-lymphocyte, lymphocyte-to-monocyte and platelet-to-lymphocyte ratios as predictors of disease severity in COVID-19 patients. Infez Med (2021) 29:46&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">33664172</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R, Hu S, Chen P, Jiang J, Cui G, Wang DW. Saving critically ill COVID-19 patients with mechanical circulatory support. Ann TranslMed (2021) 9:1221. doi:&#xa0;10.21037/atm-20-5169</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm-20-5169</ArticleId><ArticleId IdType="pmc">PMC8421987</ArticleId><ArticleId IdType="pubmed">34532358</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Li J, Zhou M, Chen Z. Summary of 20 tracheal intubation by anesthesiologists for patients with severe COVID-19 pneumonia: retrospective case series. J Anesth (2020) 34:599&#x2013;606. doi:&#xa0;10.1007/s00540-020-02778-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-020-02778-8</ArticleId><ArticleId IdType="pmc">PMC7164839</ArticleId><ArticleId IdType="pubmed">32303885</ArticleId></ArticleIdList></Reference><Reference><Citation>Martha JW, Wibowo A, Pranata R. Prognostic value of elevated lactate dehydrogenase in patients with COVID-19: a systematic review and meta-analysis. Postgrad Med J (2022) 98:422&#x2013;7. doi:&#xa0;10.1136/postgradmedj-2020-139542</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/postgradmedj-2020-139542</ArticleId><ArticleId IdType="pubmed">33452143</ArticleId></ArticleIdList></Reference><Reference><Citation>Iepsen UW, Plovsing RR, Tjelle K, Foss NB, Meyhoff CS, Ryrs&#xf8; CK, et al. . The role of lactate in sepsis and COVID-19: Perspective from contracting skeletal muscle metabolism. Exp Physiol (2022) 107:665&#x2013;73. doi:&#xa0;10.1113/EP089474</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/EP089474</ArticleId><ArticleId IdType="pmc">PMC8239768</ArticleId><ArticleId IdType="pubmed">34058787</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet (2022) 399:2263&#x2013;4. doi:&#xa0;10.1016/S0140-6736(22)00941-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Daines L, Zheng B, Pfeffer P, Hurst JR, Sheikh A. A clinical review of long-COVID with a focus on the respiratory system. Curr Opin Pulm Med (2022) 28:174&#x2013;9. doi:&#xa0;10.1097/MCP.0000000000000863</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCP.0000000000000863</ArticleId><ArticleId IdType="pmc">PMC7612723</ArticleId><ArticleId IdType="pubmed">35131989</ArticleId></ArticleIdList></Reference><Reference><Citation>Indo HP, Davidson M, Yen H-C, Suenaga S, Tomita K, Nishii T, et al. . Evidence of ROS generation by mitochondria in cells with impaired electron transport chain and mitochondrial DNA damage. Mitochondrion (2007) 7:106&#x2013;18. doi:&#xa0;10.1016/j.mito.2006.11.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2006.11.026</ArticleId><ArticleId IdType="pubmed">17307400</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganji R, Reddy PH. Impact of COVID-19 on mitochondrial-based immunity in aging and age-related diseases. Front Aging Neurosci (2021) 12:614650. doi:&#xa0;10.3389/fnagi.2020.614650</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2020.614650</ArticleId><ArticleId IdType="pmc">PMC7835331</ArticleId><ArticleId IdType="pubmed">33510633</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu K, Zou J, Chang HY. RNA-GPS predicts SARS-coV-2 RNA localization to host mitochondria and nucleolus. bioRxiv (2020) 2020:4. doi:&#xa0;10.1101/2020.04.28.065201</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.04.28.065201</ArticleId><ArticleId IdType="pmc">PMC7305881</ArticleId><ArticleId IdType="pubmed">32673562</ArticleId></ArticleIdList></Reference><Reference><Citation>Padhan K, Minakshi R, Towheed MAB, Jameel S. Severe acute respiratory syndrome coronavirus 3a protein activates the mitochondrial death pathway through p38 MAP kinase activation. J Gen Virol (2008) 89(Pt 8):1960&#x2013;9. doi:&#xa0;10.1099/vir.0.83665-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.83665-0</ArticleId><ArticleId IdType="pubmed">18632968</ArticleId></ArticleIdList></Reference><Reference><Citation>Cumpstey AF, Clark AD, Santolini J, Jackson AA, Feelisch M. COVID-19: A redox disease-what a stress pandemic can teach us about resilience and what we may learn from the reactive species interactome about its treatment. Antioxid Redox Signal (2021) 35:1226&#x2013;68. doi:&#xa0;10.1089/ars.2021.0017</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2021.0017</ArticleId><ArticleId IdType="pubmed">33985343</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen TH, Chang CJ, Hung PH. Possible pathogenesis and prevention of long COVID: SARS-coV-2-induced mitochondrial disorder. Int J Mol Sci (2023) 24:8034. doi:&#xa0;10.3390/ijms24098034</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24098034</ArticleId><ArticleId IdType="pmc">PMC10179190</ArticleId><ArticleId IdType="pubmed">37175745</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>